President Donald Trump said Monday he's in no rush to respond to a coordinated attack that hit Saudi Arabia's oil industry over the weekend.Marketsread more
The price of oil could go sharply higher, depending on the duration of the disruption at Saudi oil facilities and whether there is a military response.Powering the Futureread more
Energy stocks, one of the worst-performing sectors this year, spiked Monday after an attack on Saudi Arabia's heart of oil production Saturday sent oil prices soaring.Marketsread more
The Saudi-led military coalition battling Yemen's Houthi movement said on Monday that the attack on Saudi oil plants was carried out by Iranian weapons and did not originate...Oilread more
"The United States military, with our interagency team, is working with our partners to address this unprecedented attack and defend the international rules-based order that...Politicsread more
Crude oil's spike following attacks on Saudi Arabia's energy supply has experts weighing whether or not the gains will last.ETF Edgeread more
Traders in the fed funds futures market on Monday were pricing in a 34% chance that the Fed will stay put on rates.The Fedread more
Gas prices could rise by about 20 cents per gallon "starting tomorrow," oil analyst Andy Lipow says Monday.Oil and Gasread more
Some operators are cashing in on the CBD craze by substituting cheap and illegal synthetic marijuana for natural CBD in vapes and edibles such as gummy bears, an AP...Health and Scienceread more
Attack on Saudi oil facilities shows that 'risk is real', Chevron CEO Michael Wirth said on CNBC's "Closing Bell" Monday.Marketsread more
J.P. Morgan's chief quant says oil prices would start to hurt stock prices when they hit the $80 to $85 range.Market Insiderread more
Drug prices are still climbing despite calls to lower them, Axios reports.
President Donald Trump has repeatedly chastised the pharmaceutical industry, even accusing them of "getting away with murder." But since he took office, drugmakers have hiked list prices on hundreds of drugs at rates that outpace inflation, according to Axios, citing an analysis from Pharmacy Benefit Consultants.
List prices are the amount manufacturers set and don't include rebates and discounts. Patients with insurance don't pay these prices, though people who are uninsured may.
Within the 14-month period, 39 drugs were hiked more than 100 percent, though most of them aren't commonly used, Axios notes. The largest spike was 1,468 percent for SynerDerm, a skin cream that helps keep a moist wound and skin environment to help with healing.
More commonly used medications also saw increases, though not quite as high as some of the rare drugs. AbbVie hiked the price of Humira, the best-selling prescription in the world, 19 percent over the 14-month period. Humira treats certain types of arthritis, Crohn's disease and other ailments.